RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Mesothelioma
Accession: DOID:9003566
browse the term
Definition: A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
Synonyms: exact_synonym: Mesotheliomas
primary_id: MESH:D008654
xref: EFO:0000588 ; NCI:C21619
G
APC
APC regulator of WNT signaling pathway
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17659810
NCBI chr 2:116,913,354...116,985,303
Ensembl chr 2:116,812,582...117,034,887
G
BAP1
BRCA1 associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21642991 PMID:21874000 PMID:26119930 PMID:26719535
NCBI chr13:34,544,570...34,553,538
Ensembl chr13:34,544,581...34,553,483
G
BCL10
BCL10 immune signaling adaptor
ISO
ClinVar Annotator: match by term: Mesothelioma
ClinVar
PMID:9989495 PMID:10380920 PMID:10408400
NCBI chr 4:130,645,427...130,653,317
Ensembl chr 4:130,645,216...130,657,995
G
BIRC3
baculoviral IAP repeat containing 3
ameliorates
ISO
mRNA:increased expression:mesothelium (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 9:33,003,570...33,020,252
Ensembl chr 9:33,003,276...33,020,242
G
BIRC5
baculoviral IAP repeat containing 5
exacerbates
ISO
mRNA:increased expression:mesothelium (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
CAT
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11283936
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CDH1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15639718
NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18301454
NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831
G
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism DNA:deletion
CTD RGD
PMID:18379362 PMID:20065947
RGD:7248760
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
CDKN2B
cyclin dependent kinase inhibitor 2B
ISO
DNA:deletion
RGD
PMID:20065947
RGD:7248760
NCBI chr 1:200,666,250...200,770,880
Ensembl chr 1:200,761,004...200,766,056
G
DIO2
iodothyronine deiodinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11425850
NCBI chr 7:103,096,414...103,110,749
Ensembl chr 7:103,096,433...103,323,258
G
EGFR
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21787763
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
EGR1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15878867
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
G
EID1
EP300 interacting inhibitor of differentiation 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15920167
NCBI chr 1:122,810,484...122,812,481
Ensembl chr 1:122,811,556...122,812,131
G
EPHX1
epoxide hydrolase 1
ISO
RGD
PMID:16697254
RGD:4889125
NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15639718 PMID:17659810
RGD:4892302
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
FGF1
fibroblast growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15878867
NCBI chr 2:144,133,846...144,241,345
Ensembl chr 2:144,133,392...144,241,323
G
FGF2
fibroblast growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15878867
NCBI chr 8:101,278,877...101,344,084
Ensembl chr 8:101,278,885...101,343,916
G
FHIT
fragile histidine triad diadenosine triphosphatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14569398 PMID:18038314
NCBI chr13:41,443,963...42,884,799
Ensembl chr13:41,443,965...42,392,817
G
GDF10
growth differentiation factor 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18949431
NCBI chr14:88,522,956...88,534,719
Ensembl chr14:88,522,948...88,534,709
G
GPC3
glypican 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10656689
NCBI chr X:109,536,495...109,973,605
Ensembl chr X:109,536,504...109,973,607
G
GSN
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15920167
NCBI chr 1:261,295,711...261,372,848
Ensembl chr 1:261,307,008...261,372,848
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12768194
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
JMJD6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30619488
NCBI chr12:4,809,014...4,819,853
Ensembl chr12:4,809,118...4,818,043
G
LOC100524016
mesothelin
ISO
protein:increased secretion:body fluid CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11751476 PMID:17785569 PMID:18394747 PMID:18505465 PMID:20933535
RGD:2326046 RGD:2326062
NCBI chr 3:41,025,892...41,029,302
G
MTOR
mechanistic target of rapamycin kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21358348
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
MUC1
mucin 1, cell surface associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18454162
NCBI chr 4:94,626,317...94,631,194
G
MYO18B
myosin XVIIIB
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17294804
NCBI chr14:43,467,823...43,687,729
Ensembl chr14:43,468,514...43,687,727
G
NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12136076 PMID:12168054 PMID:12802287 PMID:16166281 PMID:16319530 PMID:18835652 More...
NCBI chr14:46,653,869...46,726,421
Ensembl chr14:46,653,900...46,731,999
G
NME2
NME/NM23 nucleoside diphosphate kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15920167
NCBI chr12:27,439,529...27,445,025
Ensembl chr12:27,439,260...27,445,027
G
PDGFA
platelet derived growth factor subunit A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11415934
NCBI chr 3:296,399...322,967
Ensembl chr 3:301,584...321,712
G
PDGFC
platelet derived growth factor C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15920167
NCBI chr 8:45,579,065...45,808,789
Ensembl chr 8:45,578,002...45,808,748
G
PGR
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15639718
NCBI chr 9:32,035,684...32,129,776
Ensembl chr 9:32,035,684...32,129,221
G
PPP1R14A
protein phosphatase 1 regulatory inhibitor subunit 14A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18835652
NCBI chr 6:47,167,105...47,174,299
Ensembl chr 6:47,167,118...47,174,091
G
PUF60
poly(U) binding splicing factor 60
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21435101
NCBI chr 4:812,137...824,321
Ensembl chr 4:812,131...824,318
G
RASSF1
Ras association domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12082623 PMID:15639718
NCBI chr13:32,816,156...32,825,486
Ensembl chr13:32,816,156...32,825,226
G
SLC6A20
solute carrier family 6 member 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17659810
NCBI chr13:28,897,831...28,945,191
Ensembl chr13:28,899,821...28,945,187
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9533946 PMID:11283936 PMID:15039138 PMID:17290392
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16221779 PMID:18550471
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
SYK
spleen associated tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17659810
NCBI chr14:2,103,706...2,160,886
Ensembl chr14:2,056,670...2,161,171
G
TNC
tenascin C
disease_progression
ISO
RGD
PMID:12605648 PMID:16928692
RGD:4889571 RGD:4889612
NCBI chr 1:255,533,235...255,630,381
Ensembl chr 1:255,533,238...255,630,376
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12151629
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TXNRD1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17316382
NCBI chr 5:80,170,334...80,213,889
Ensembl chr 5:80,172,260...80,236,219
G
WT1
WT1 transcription factor
ISO
ClinVar Annotator: match by term: Mesothelioma
ClinVar
PMID:4332312 PMID:8298644
NCBI chr 2:28,411,467...28,456,007
Ensembl chr 2:28,411,803...28,455,997
G
XIAP
X-linked inhibitor of apoptosis
ameliorates
ISO
mRNA:increased expression:mesothelium (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr X:101,399,374...101,440,021
Ensembl chr X:101,399,812...101,440,013
G
XRCC1
X-ray repair cross complementing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564556 PMID:20705543
NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,689...50,425,729
G
XRCC3
X-ray repair cross complementing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564556
G
TRAF7
TNF receptor associated factor 7
ISO
DNA:missense mutations:multiple
RGD
PMID:29148537
RGD:151356962
NCBI chr 3:39,811,803...39,828,450
Ensembl chr 3:39,810,606...39,828,395
G
ACVR1B
activin A receptor type 1B
ameliorates
ISO
RGD
PMID:30061637
RGD:151665492
NCBI chr 5:17,314,322...17,350,726
Ensembl chr 5:17,314,276...17,350,722
G
ADA
adenosine deaminase
treatment
ISO
RGD
PMID:17952507
RGD:152995277
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
G
ADAMTS2
ADAM metallopeptidase with thrombospondin type 1 motif 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26139392
NCBI chr 2:79,182,901...79,406,879
Ensembl chr 2:79,182,943...79,406,875
G
AGO1
argonaute RISC component 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 6:92,038,104...92,076,477
Ensembl chr 6:91,984,303...92,215,149
G
AGO2
argonaute RISC catalytic component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 4:2,966,794...3,012,388
Ensembl chr 4:2,919,511...3,015,334
G
ANXA2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20682992
NCBI chr 1:111,588,721...111,635,064
Ensembl chr 1:111,588,306...111,635,059
G
APOA1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
G
BAP1
BRCA1 associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:24928783 PMID:25231345 PMID:26463840 PMID:26928227 PMID:29112861
RGD:9586039
NCBI chr13:34,544,570...34,553,538
Ensembl chr13:34,544,581...34,553,483
G
BCL10
BCL10 immune signaling adaptor
ISO
ClinVar Annotator: match by term: Mesothelioma, malignant | ClinVar Annotator: match by term: Mesothelioma, somatic
OMIM ClinVar
PMID:9989495 PMID:10380920 PMID:10408400 PMID:25741868 PMID:28492532
NCBI chr 4:130,645,427...130,653,317
Ensembl chr 4:130,645,216...130,657,995
G
BCL2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16850164
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
C9
complement C9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr16:24,521,318...24,575,939
Ensembl chr16:24,520,634...24,590,338
G
CALB2
calbindin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 6:14,392,220...14,420,663
Ensembl chr 6:14,391,857...14,420,663
G
CCL27
C-C motif chemokine ligand 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr10:32,138,232...32,138,980
Ensembl chr10:32,138,232...32,138,974
G
CCL3L1
chemokine (C-C motif) ligand 3-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr12:39,491,999...39,493,345
Ensembl chr12:39,491,914...39,493,774
G
CCL5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
CCNE2
cyclin E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 4:41,802,090...41,821,870
Ensembl chr 4:41,804,377...41,821,874
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:22002241
RGD:11522742
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
CDH5
cadherin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr 6:27,108,560...27,142,145
Ensembl chr 6:27,108,597...27,142,177
G
CDK6
cyclin dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 9:72,510,858...72,765,631
Ensembl chr 9:72,518,101...72,764,129
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11453316
NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,359,455...32,363,761
G
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19223589 PMID:21526190 PMID:29112861
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
CFAP45
cilia and flagella associated protein 45
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr 4:90,593,864...90,626,660
Ensembl chr 4:90,593,858...90,627,800
G
CLDN10
claudin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr11:65,027,706...65,145,002
Ensembl chr11:65,121,607...65,145,072
G
CLDN15
claudin 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr 3:8,931,099...8,937,189
Ensembl chr 3:8,931,097...8,937,184
G
CLDN4
claudin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr 3:11,039,711...11,053,930
Ensembl chr 3:11,039,706...11,053,925
G
CLDN5
claudin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr14:51,161,490...51,162,382
Ensembl chr14:51,161,042...51,163,482
G
CLDN8
claudin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr13:193,563,314...193,564,090
Ensembl chr13:193,562,074...193,564,168
G
CLEC11A
C-type lectin domain containing 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 6:55,502,892...55,505,690
Ensembl chr 6:55,496,746...55,506,550
G
COL12A1
collagen type XII alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 1:90,744,409...90,875,127
Ensembl chr 1:90,744,612...90,875,118
G
COPG1
COPI coat complex subunit gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26463840
NCBI chr13:71,707,097...71,730,402
Ensembl chr13:71,672,733...71,730,399
G
CSF1
colony stimulating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 4:110,178,466...110,198,232
Ensembl chr 4:110,178,475...110,197,900
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr14:91,516,383...91,543,857
Ensembl chr14:91,516,431...91,552,752
G
CXCL13
C-X-C motif chemokine ligand 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 8:73,071,261...73,077,342
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674 PMID:28377727
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
G
DDX3X
DEAD-box helicase 3 X-linked
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr X:36,988,031...37,005,496
Ensembl chr X:36,988,031...37,018,202
G
DDX51
DEAD-box helicase 51
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr14:23,262,738...23,269,905
Ensembl chr14:23,262,776...23,270,896
G
EFEMP1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27032653
NCBI chr 3:85,407,677...85,473,251
Ensembl chr 3:85,407,677...85,473,252
G
EGFR
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27032653
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
ENOX2
ecto-NOX disulfide-thiol exchanger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26807072
NCBI chr X:107,084,378...107,368,520
Ensembl chr X:107,085,503...107,368,473
G
EPHX1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16697254
NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
G
F9
coagulation factor IX
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr X:114,218,704...114,250,436
Ensembl chr X:114,218,707...114,250,429
G
FGD6
FYVE, RhoGEF and PH domain containing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 5:88,087,032...88,229,807
Ensembl chr 5:88,104,899...88,221,828
G
FGF18
fibroblast growth factor 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr16:52,724,867...52,760,246
Ensembl chr16:52,725,356...52,759,791
G
FGF9
fibroblast growth factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr11:1,554,648...1,581,938
Ensembl chr11:1,554,763...1,582,408
G
FN1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr15:117,658,158...117,737,145
Ensembl chr15:117,658,099...117,731,014
G
FTH1
ferritin heavy chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26818092
NCBI chr 2:9,535,051...9,537,979
G
GPR27
G protein-coupled receptor 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr13:53,152,038...53,154,537
Ensembl chr13:53,152,062...53,153,192
G
GPR37
G protein-coupled receptor 37
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr18:23,019,752...23,036,483
Ensembl chr18:23,019,749...23,038,356
G
HDAC4
histone deacetylase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr15:138,378,237...138,657,266
Ensembl chr15:138,381,635...138,614,301
G
HEPH
hephaestin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26818092
NCBI chr X:52,314,911...52,397,384
Ensembl chr X:52,314,935...52,397,380
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
HTRA1
HtrA serine peptidase 1
disease_progression
ISO
protein:increased expression:mesothelium (human)
RGD
PMID:18681782
RGD:152975625
NCBI chr14:132,043,044...132,103,590
Ensembl chr14:132,041,934...132,103,595
G
ICAM2
intercellular adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr12:14,986,636...14,991,639
Ensembl chr12:14,972,852...14,997,428
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IGF2BP3
insulin like growth factor 2 mRNA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23621518
NCBI chr 9:92,104,786...92,272,264
Ensembl chr 9:92,104,848...92,272,211
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr16:64,143,268...64,158,929
Ensembl chr16:64,143,268...64,158,929
G
IL1A
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr10:64,948,149...65,001,320
Ensembl chr10:64,948,563...65,001,142
G
IL4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
ILK
integrin linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23045294
NCBI chr 9:3,145,647...3,152,097
Ensembl chr 9:3,145,608...3,159,858
G
KAT5
lysine acetyltransferase 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26780987
NCBI chr 2:6,560,544...6,572,461
Ensembl chr 2:6,560,513...6,572,466
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
G
LIMCH1
LIM and calponin homology domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 8:32,433,035...32,792,553
Ensembl chr 8:32,433,318...32,792,546
G
LOC100157117
kallistatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 7:115,781,772...115,792,469
Ensembl chr 7:115,783,931...115,792,466
G
LOC100516039
C-C motif chemokine 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr12:39,591,521...39,595,639
G
LOC100524016
mesothelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19190155 PMID:27032653
NCBI chr 3:41,025,892...41,029,302
G
LTA
lymphotoxin alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 7:23,696,387...23,698,280
Ensembl chr 7:23,696,040...23,698,299
G
MCAM
melanoma cell adhesion molecule
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22784439 PMID:23621518
RGD:7364782
NCBI chr 9:46,506,375...46,522,091
Ensembl chr 9:46,512,784...46,522,083
G
MDK
midkine
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 2:16,130,787...16,133,791
Ensembl chr 2:16,130,788...16,133,510
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
MIF
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MIR125A
microRNA mir-125a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 6:58,331,566...58,331,645
Ensembl chr 6:58,331,566...58,331,645
G
MIR126
microRNA mir-126
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21483773
G
MIR32
microRNA mir-32
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27716620
NCBI chr 1:250,115,904...250,115,973
Ensembl chr 1:250,115,904...250,115,973
G
MLANA
melan-A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 1:216,230,472...216,247,171
Ensembl chr 1:216,232,832...216,245,359
G
MTMR4
myotubularin related protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr12:34,745,232...34,771,315
Ensembl chr12:34,745,236...34,771,167
G
MUC1
mucin 1, cell surface associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 4:94,626,317...94,631,194
G
NANOS1
nanos C2HC-type zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr14:128,962,311...128,964,207
Ensembl chr14:128,962,375...128,963,229
G
NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16166281 PMID:23435014 PMID:26463840 PMID:26678224 PMID:26928227 PMID:29112861 PMID:32271879 More...
RGD:150530636 RGD:150530640
NCBI chr14:46,653,869...46,726,421
Ensembl chr14:46,653,900...46,731,999
G
NGF
nerve growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 4:105,256,691...105,307,843
Ensembl chr 4:105,256,749...105,307,837
G
OSMR
oncostatin M receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr16:24,041,312...24,101,842
Ensembl chr16:24,041,567...24,102,177
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21543585
NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,160...14,241,196
G
PDPN
podoplanin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 6:73,019,063...73,050,000
Ensembl chr 6:73,019,057...73,049,996
G
PLLP
plasmolipin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 6:19,214,037...19,241,251
Ensembl chr 6:19,211,761...19,241,228
G
PTPRF
protein tyrosine phosphatase receptor type F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 6:167,656,674...167,743,750
Ensembl chr 6:167,657,680...167,743,721
G
PYCARD
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26935421
NCBI chr 3:17,305,921...17,307,521
Ensembl chr 3:17,306,099...17,307,786
G
RAF1
Raf-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr13:68,581,128...68,657,911
Ensembl chr13:68,580,812...68,657,829
G
RXRA
retinoid X receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 1:273,698,842...273,797,622
Ensembl chr 1:273,705,505...273,797,620
G
RYR2
ryanodine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr14:53,652,140...54,406,691
Ensembl chr14:53,652,485...54,192,063
G
S100B
S100 calcium binding protein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
G
SDC1
syndecan 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27032653
NCBI chr 3:117,987,585...118,011,886
Ensembl chr 3:117,987,557...118,011,884
G
SEMA4F
ssemaphorin 4F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 3:68,377,669...68,404,662
Ensembl chr 3:68,379,322...68,404,595
G
SETD2
SET domain containing 2, histone lysine methyltransferase
ISO
CTD Direct Evidence: marker/mechanism DNA:mutations:multiple (human)
CTD RGD
PMID:26928227 PMID:27834213
RGD:150429641
NCBI chr13:29,884,708...29,996,285
Ensembl chr13:29,884,719...29,996,359
G
SETDB1
SET domain bifurcated histone lysine methyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr 4:98,259,801...98,293,238
Ensembl chr 4:98,260,375...98,293,097
G
SF3B1
splicing factor 3b subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr15:101,274,968...101,338,018
Ensembl chr15:101,276,851...101,299,105
G
SHBG
sex hormone binding globulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr12:52,914,711...52,919,092
G
SLC22A5
solute carrier family 22 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 2:134,660,741...134,847,575
Ensembl chr 2:134,660,808...134,686,219
G
SLC2A1
solute carrier family 2 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 6:168,535,398...168,561,170
Ensembl chr 6:168,535,440...168,560,867
G
SMARCA2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 1:219,624,773...219,815,438
Ensembl chr 1:219,573,535...219,815,421
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20617513
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
TBL1XR1
TBL1X/Y related 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr13:115,312,444...115,488,228
Ensembl chr13:115,312,452...115,487,284
G
TF
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26818092
NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
G
TFDP2
transcription factor Dp-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr13:82,752,446...82,937,790
Ensembl chr13:82,752,458...82,937,668
G
TGFB2
transforming growth factor beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr10:8,306,136...8,435,307
Ensembl chr10:8,305,539...8,390,341
G
TNFRSF8
TNF receptor superfamily member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 6:72,103,309...72,174,882
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TRAF7
TNF receptor associated factor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr 3:39,811,803...39,828,450
Ensembl chr 3:39,810,606...39,828,395
G
TXN
thioredoxin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27032653
NCBI chr 1:251,264,180...251,278,000
Ensembl chr 1:251,263,175...251,277,988
G
ULK2
unc-51 like autophagy activating kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr12:59,806,904...59,878,398
Ensembl chr12:59,806,955...59,878,388
G
VIM
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr10:43,516,441...43,526,172
Ensembl chr10:43,517,307...43,526,170
G
WT1
WT1 transcription factor
ISO
ClinVar Annotator: match by term: Mesothelioma, malignant
OMIM ClinVar
PMID:1302008 PMID:1327525 PMID:1338906 PMID:1655284 PMID:1658787 PMID:6307071 PMID:7795587 PMID:8295405 PMID:9090524 PMID:9398852 PMID:9499425 PMID:9529364 PMID:9536098 PMID:9607189 PMID:9745866 PMID:10470095 PMID:10505700 PMID:10762296 PMID:11182928 PMID:12970737 PMID:15150775 PMID:15509792 PMID:17496156 PMID:17541636 PMID:17576681 PMID:17694336 PMID:17853480 PMID:20442690 PMID:21499692 PMID:21508141 PMID:22099579 PMID:23295293 PMID:23497137 PMID:23515051 PMID:23715653 PMID:23935527 PMID:24033266 PMID:24856380 PMID:25501161 PMID:25741868 PMID:25818337 PMID:26069768 PMID:26248470 PMID:26467025 PMID:27013732 PMID:27719739 PMID:27899157 PMID:28204945 PMID:28492532 PMID:28780565 PMID:29474669 PMID:30406062 PMID:30963316 PMID:32352694 PMID:32581362 PMID:32604935 PMID:34490048 More...
NCBI chr 2:28,411,467...28,456,007
Ensembl chr 2:28,411,803...28,455,997
G
WWC1
WW and C2 domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr16:55,418,391...55,595,202
Ensembl chr16:55,418,397...55,595,189
G
XRCC1
X-ray repair cross complementing 1
treatment
ISO
RGD
PMID:22982660
RGD:151347428
NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,689...50,425,729
G
BAP1
BRCA1 associated protein 1
disease_progression
ISO
RGD
PMID:27422796
RGD:127229946
NCBI chr13:34,544,570...34,553,538
Ensembl chr13:34,544,581...34,553,483
G
BIRC5
baculoviral IAP repeat containing 5
exacerbates
ISO
mRNA:increased expression:pleura, lung (human)
RGD
PMID:17253596
RGD:153344528
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
BIRC7
baculoviral IAP repeat containing 7
ameliorates
ISO
mRNA:increased expression:pleura, lung (human)
RGD
PMID:17253596
RGD:153344528
NCBI chr17:62,351,663...62,356,220
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ameliorates
ISO
RGD
PMID:18722110
RGD:151667912
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123
G
CSF1R
colony stimulating factor 1 receptor
ISO
mRNA:increased expression:peritoneum�� (human)
RGD
PMID:24722292
RGD:150524278
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
EMX2
empty spiracles homeobox 2
exacerbates
ISO
mRNA:decreased expression:mesothelium of pleural cavity (human)
RGD
PMID:25023662
RGD:153323312
NCBI chr14:127,649,675...127,656,972
Ensembl chr14:127,650,688...127,655,706
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
disease_progression
ISO
mRNA, protein:increased expression:pleura
RGD
PMID:22028491
RGD:126781718
NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941
G
IL7R
interleukin 7 receptor
disease_progression
ISO
RGD
PMID:26155428
RGD:151347688
NCBI chr16:21,300,141...21,330,156
Ensembl chr16:21,300,111...21,329,585
G
KDM6A
lysine demethylase 6A
ISO
mRNA:increased expression:mesothelium of pleural cavity (human)
RGD
PMID:28197626
RGD:150429737
NCBI chr X:39,953,764...40,154,197
Ensembl chr X:39,953,814...40,154,029
G
MIR192
microRNA mir-192
ISO
miRNA:decreased expression:pleura (human)
RGD
PMID:26125439
RGD:11529530
NCBI chr 2:7,285,667...7,285,746
Ensembl chr 2:7,285,667...7,285,746
G
MIR193A
microRNA mir-193a
ISO
miRNA:decreased expression:pleura (human)
RGD
PMID:26125439
RGD:11529530
NCBI chr12:43,336,969...43,337,048
Ensembl chr12:43,336,969...43,337,048
G
MLH1
mutL homolog 1
disease_progression
ISO
RGD
PMID:23810210
RGD:126848799
NCBI chr13:21,791,276...21,877,789
Ensembl chr13:21,791,203...21,877,757
G
NCOA2
nuclear receptor coactivator 2
ameliorates
ISO
protein:increased expression:mesothelium of pleural cavity (human)
RGD
PMID:22011668
RGD:153002578
NCBI chr 4:64,888,029...65,245,757
Ensembl chr 4:64,954,238...65,246,572
G
NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
disease_progression
ISO
DNA:loss of heterozygosity
RGD
PMID:26493618 PMID:26928227 PMID:27378628
RGD:11553131 RGD:150429647 RGD:150530638
NCBI chr14:46,653,869...46,726,421
Ensembl chr14:46,653,900...46,731,999
G
RAD21
RAD21 cohesin complex component
ISO
RGD
PMID:19380173
RGD:150520037
NCBI chr 4:21,772,821...21,802,453
Ensembl chr 4:21,772,855...21,802,715
G
SETD2
SET domain containing 2, histone lysine methyltransferase
disease_progression
ISO
DNA:mutations:CDS:multiple (human)
RGD
PMID:26928227 PMID:33691361
RGD:150429647 RGD:150520202
NCBI chr13:29,884,708...29,996,285
Ensembl chr13:29,884,719...29,996,359
G
SLC7A5
solute carrier family 7 member 5
disease_progression
ISO
protein:increased expression:pleura
RGD
PMID:22199264 PMID:24912849
RGD:151361201 RGD:151660330
NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
G
SMO
smoothened, frizzled class receptor
disease_progression
ISO
DNA:missense mutations
RGD
PMID:23379358 PMID:33209614
RGD:150521620 RGD:150521621
NCBI chr18:19,450,730...19,478,796
Ensembl chr18:19,450,743...19,478,898
G
XIAP
X-linked inhibitor of apoptosis
ameliorates
ISO
mRNA:increased expression:pleura, lung (human)
RGD
PMID:17253596
RGD:153344528
NCBI chr X:101,399,374...101,440,021
Ensembl chr X:101,399,812...101,440,013
G
LATS1
large tumor suppressor kinase 1
ISO
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma
ClinVar
NCBI chr 1:16,274,955...16,320,980
Ensembl chr 1:16,274,970...16,320,604
G
LATS2
large tumor suppressor kinase 2
ISO
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma
ClinVar
NCBI chr11:1,225,523...1,265,970
Ensembl chr11:1,225,527...1,265,946
G
MECOM
MDS1 and EVI1 complex locus
ISO
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma
ClinVar
NCBI chr13:107,753,207...108,336,136
Ensembl chr13:107,754,482...108,335,702
G
TRAF7
TNF receptor associated factor 7
ISO
DNA:missense mutations:multiple
RGD
PMID:30171198
RGD:151356964
NCBI chr 3:39,811,803...39,828,450
Ensembl chr 3:39,810,606...39,828,395
G
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
DNA:deletion
RGD
PMID:20065947
RGD:7248760
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all